X @Bloomberg

Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record https://t.co/SeCRTlNnyi ...